NEUROMUSCULAR

NeurologyLive's Neuromuscular Clinical Focus page focuses on the latest news and research for rare disorders like amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), and myasthenia gravis (MG).

Comment from Irfan Qureshi, MD

Verdiperstat Aims to Be First DMT for Multiple System Atrophy

Biohaven’s verdiperstat has entered a phase 3 trial for the treatment of multiple system atrophy, with a new drug application submission on the agenda for late 2021.

Overview of Spinal Muscular Atrophy

Dr James Wymer explains what spinal muscular atrophy is and discusses how the disease typically presents in newly diagnosed patients.

OnabotulinumtoxinA sBLA Accepted for Detrusor Overactivity Due to Neurologic Conditions

The sBLA for onabotulinumtoxinA is supported by the findings from a randomized, double-blind phase 3 study evaluating the safety and efficacy of onabotulinumtoxinA in more than 100 pediatric patients.

NeurologyLive Friday 5 — June 26, 2020

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 26, 2020.

SRP-9001 Safe, Tolerable in Duchenne Muscular Dystrophy

Preliminary results showed that SRP-9001 is associated with clinically meaningful improvement that is greater than that observed with standard-of-care treatment, including corticosteroids.

Cardioversion and Atrial Fibrillation Ablation

Pimavanserin Gets NDA Nod, Ubrogepant Improves Chronic Migraine, Risdiplam Increases Motor Function

SPR1NT Trial of Onasemnogene Abeparvovec for SMA

Previous Page Next Page

About NeurologyLive's Neuromuscular Clinical Focus page:

The NeurologyLive Neuromuscular Clinical Focus page provides the latest clinical updates about neuromuscular diseases, with articles and videos covering the most up-to-date advancements in the field. Visitors to the clinical focus page will find information on emerging treatment options, as well as updates from the world’s top neurology conferences and annual meetings, including key coverage on rare disorders like ALS, DMD, and MD.

Additionally, articles and video editorial from neurologists and professionals specializing in neuromuscular conditions can be found on this page, offering expert guidance on current management strategies and potential neuromuscular therapy options.